Pfizer Parecoxib, Oporia Setbacks Reflect Tougher FDA Stance, CEO Says

Pfizer's research & development productivity has been impacted by a more difficult, risk-averse regulatory environment at FDA, CEO Hank McKinnell said during an earnings call Oct. 20